最新の財務諸表(Form-10K)によると、Entera Bio Ltdの総資産は$0で、純損失は$0です。
SBSNYの主要な財務比率は何ですか?
Entera Bio Ltdの流動比率は0、純利益率は0、1株当たり売上高は$0です。
Vend Marketplaces ASAの収益はセグメントまたは地域別にどのように分けられていますか?
Entera Bio Ltd の最大収益セグメントは Oral Tablet Formats of Peptides で、最新の利益発表における収益は 42,000 です。地域別に見ると、Israel が Entera Bio Ltd の主要市場であり、収益は 42,000 です。
Vend Marketplaces ASAは収益を上げていますか?
いいえ、最新の財務諸表によると、Entera Bio Ltdの純損失は$0です。
Vend Marketplaces ASAに負債はありますか?
いいえ、Entera Bio Ltdの負債は0です。
Vend Marketplaces ASAの発行済株式数は何株ですか?
Entera Bio Ltdの総発行済株式数は0株です。
主要データ
前終値
$26.1
始値
$26.1
当日レンジ
$26.1 - $26.1
52週レンジ
$18 - $45
取引高
100
平均取引高
9.6K
配当利回り
--
1株当たり利益(TTM)
-4.13
時価総額
$5.2B
VEND MARKETPLACES ASAとは何ですか?
Vend Marketplaces ASA operates as a digital marketplace company that connects buyers and sellers across various sectors. The company is headquartered in Oslo, Oslo and currently employs 3,884 full-time employees. The firm focuses on operating and developing online marketplaces across the Nordic region, offering platforms for buying and selling goods and services. Its primary business areas include classified ads, e-commerce, and digital services, with a presence in sectors such as real estate, jobs, mobility, and consumer goods. The Company’s key platform is its Nordic family of digital marketplaces, which are online platforms. These platforms aim to connect millions of users monthly, enabling efficient and transparent transactions between individuals and businesses. Vend Marketplaces ASA leverages technologies such as Artificial Intelligence (AI) and data analytics to personalize user experiences, optimize search and recommendation engines, and improve operational efficiency.